Abstract
BackgroundJAK inhibitors (JAKi), small molecules that inhibit the Janus kinase enzymes, are increasingly used to treat children with rheumatologic diseases. Clinical experience of JAKi in the management of adult patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
